UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 27, 2005
CABOT CORPORATION
DELAWARE
1-5667 | 04-2271897 | |
(Commission File Number) | (IRS Employer Identification No.) |
TWO SEAPORT LANE, SUITE 1300, BOSTON, MASSACHUSETTS | 02210-2019 | |
(Address of Principal Executive Offices) | (Zip Code) |
(617) 345-0100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
PRESS RELEASE DATED APRIL 27, 2005 |
Item 2.02 Results of Operations and Financial Condition.
On April 27, 2005 Cabot Corporation issued a press release dated April 27, 2005 announcing its operating results for the second quarter of fiscal year 2005. A copy of the press release is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press release issued by Cabot Corporation on April 27, 2005
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CABOT CORPORATION | ||
By: /s/ John A. Shaw | ||
Name: John A. Shaw | ||
Title: Executive Vice President | ||
and Chief Financial Officer |
Date: April 27, 2005
Exhibit 99.1
Contact:
|
Susannah R. Robinson | |
Director, Investor Relations | ||
(617) 342-6129 |
FOR IMMEDIATE RELEASE
CABOT ANNOUNCES SECOND QUARTER OPERATING RESULTS
BOSTON, MA (April 27, 2005) Cabot Corporation (CBT/NYSE) today announced a net loss of $50 million (loss of $0.84 per common share) for the second quarter of fiscal year 2005 ended March 31, 2005, compared with earnings of $37 million ($0.54 per diluted common share) for the year ago quarter. The second quarter fiscal year 2005 results included $93 million ($1.46 per common share after tax) of charges from certain items and discontinued operations, compared with $1 million ($0.02 per diluted common share after tax) of charges from certain items and discontinued operations for the same quarter of fiscal year 2004. After analyzing current and anticipated tantalum market conditions, Cabot wrote off the goodwill associated with the Supermetals Business ($90 million). Further details concerning charges from certain items and discontinued operations and results for the quarter are included in Exhibit I to this press release and in the quarterly Supplemental Business Information, which is available on Cabots website in the Investor Relations section: http://investor.cabot-corp.com.
Kennett F. Burnes, Cabots Chairman and CEO, commented, The tantalum industry has seen a continued movement toward the use of ever smaller tantalum capacitors in electronics devices resulting in significantly less tantalum powder being used in each capacitor. This development, along with continued high inventory levels that exist in the supply chain, is putting significant pressure on tantalum powder volumes and prices. These adverse market conditions coincide with the expiration of our fixed price contracts over the next two years and have caused
Page 1 of 4
us to lower our expectations for the future performance of the Supermetals Business. Our lowered expectations prompted an analysis under the accounting rules which indicated that the current net book value of the assets exceeded the estimated fair value of the business, and caused us to write off $90 million of goodwill.
The Supermetals Business reported operating profit of $16 million for the second quarter of fiscal 2005 which was equal to the profit for the second quarter of 2004 and the first quarter of 2005 due to higher non-contracted volumes offset by lower prices. The weak market environment has also caused us to reduce our expectations for this businesss performance in the current fiscal year, added Burnes.
We saw solid performance for the quarter within our Chemicals Business, particularly in carbon black, where customer demand remains strong, said Burnes. The Chemicals Business reported operating profit of $46 million compared with $43 million for the second quarter of fiscal 2004 and $36 million for the first quarter of 2005. Continued high capacity utilization in the carbon black business has allowed us to expand our profitability in this business, increasing operating profit by $6 million compared with the same period last year and $12 million over the first quarter of 2005, continued Burnes. Cabots fumed metal oxides business reported a $2 million decrease in operating profit compared to the second quarter of 2004 and a $1 million decrease compared to the first quarter of 2005. The results for the quarter were impacted by a write off related to off quality material. We continue to believe that the fumed metal oxides business remains strong and healthy, added Burnes. Inkjet colorants reported volume growth of 18% over the year ago quarter and 5% over the first quarter of fiscal 2005 driven by increased demand in both the aftermarket and OEM segments.
Page 2 of 4
During the second quarter, the Specialty Fluids Business reported operating profit of $4 million versus $3 million in the same period of fiscal 2004 and $2 million in the first quarter of 2005 driven by an increased number of rental days. During the quarter, the business completed six jobs compared to four jobs for the same period last year.
We are optimistic about the Companys performance overall, said Burnes, and anticipate continued strong volumes in our core Chemicals Business as well as ongoing growth in the inkjet colorants and Specialty Fluids businesses. We continue to invest resources in market development and manufacturing operations for our new businesses, such as aerogels, and are confident that they will be solid contributors in future years. Notwithstanding the current challenges in the Supermetals Business, we remain optimistic about its long term performance.
Cabot Corporation is a global specialty chemicals and materials company headquartered in Boston, MA. Cabots major products are carbon black, fumed silica, inkjet colorants, capacitor materials, and cesium formate drilling fluids.
Forward-Looking Information: This press release contains forward-looking statements, particularly regarding market development plans, Cabots overall future performance, new business growth, and managements expectations and outlook for the Companys businesses. These statements are based on managements current expectations, assumptions, estimates and projections about Cabots businesses and the industries in which Cabot operates. Actual results may differ materially from those forecast or implied in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which are current only as of this date. Cabot undertakes no obligation to publicly update and revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
While the list below is not exhaustive, some factors that could affect Cabots future operating results, financial position and cash flows and could cause actual results to differ materially from those expressed in the forward looking statements are: domestic and global economic conditions, such as market supply and demand, costs and availability of raw materials; the results of current and anticipated labor negotiations; changes in capacity utilization; fluctuations in
Page 3 of 4
currency exchange rates; the timely commercialization of products under development by Cabot (which may be disrupted or delayed by technical difficulties, market acceptance, competitors new products, as well as difficulties in moving from the experimental stage to the production stage); demand for our customers products; and competitors reactions to market conditions. Other factors and risks affecting Cabot are discussed in our 2004 Annual Report on Form 10-K.
#####
Page 4 of 4
Second Quarter Earnings Announcement, Fiscal 2005
CABOT CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS
Periods ended March 31 | Three Months | Six Months | ||||||||||||||
Dollars in millions, except per share amounts (unaudited) | 2005 | 2004 | 2005 | 2004 | ||||||||||||
Net sales and other operating revenues |
$ | 527 | $ | 500 | $ | 1,022 | $ | 946 | ||||||||
Cost of sales |
397 | 369 | 775 | 708 | ||||||||||||
Gross profit |
$ | 130 | $ | 131 | $ | 247 | $ | 238 | ||||||||
Selling and administrative expenses |
56 | 58 | 110 | 109 | ||||||||||||
Research and technical expenses |
15 | 13 | 30 | 25 | ||||||||||||
Goodwill asset impairment |
90 | | 90 | | ||||||||||||
Income (loss) from operations |
($31 | ) | $ | 60 | $ | 17 | $ | 104 | ||||||||
Other income and expense |
||||||||||||||||
Interest and dividend income |
1 | 1 | 3 | 3 | ||||||||||||
Interest expense |
(8 | ) | (7 | ) | (16 | ) | (15 | ) | ||||||||
Other income (expense) |
3 | (3 | ) | 5 | (4 | ) | ||||||||||
Total other income and expense |
(4 | ) | (9 | ) | (8 | ) | (16 | ) | ||||||||
Income (loss) from continuing operations before income taxes |
(35 | ) | 51 | 9 | 88 | |||||||||||
Provision for income taxes |
(13 | ) | (13 | ) | (22 | ) | (21 | ) | ||||||||
Equity in net income of affiliated companies, net of tax |
2 | 1 | 4 | 3 | ||||||||||||
Minority interest in net income, net of tax |
(4 | ) | (3 | ) | (6 | ) | (4 | ) | ||||||||
Income (loss) from continuing operations |
(50 | ) | 36 | (15 | ) | 66 | ||||||||||
Discontinued operations |
||||||||||||||||
Income from operations of discontinued businesses, net of tax |
| 1 | | | ||||||||||||
Net income (loss) |
(50 | ) | 37 | (15 | ) | 66 | ||||||||||
Dividends on preferred stock |
| (1 | ) | (1 | ) | (2 | ) | |||||||||
Income (loss) available to common shares |
$ | (50 | ) | $ | 36 | $ | (16 | ) | $ | 64 | ||||||
Diluted earnings per share of common stock |
||||||||||||||||
Income (loss) from continuing operations |
$ | (0.84 | ) | $ | 0.53 | $ | (0.26 | ) | $ | 0.96 | ||||||
Income from operations of discontinued businesses |
$ | | $ | 0.01 | $ | | $ | | ||||||||
Net income (loss) |
$ | (0.84 | ) | $ | 0.54 | $ | (0.26 | ) | $ | 0.96 | ||||||
Weighted average common shares outstanding |
||||||||||||||||
Diluted (A) |
60 | 69 | 60 | 69 |
(A) | The weighted average common shares outstanding at March 31, 2005 excludes approximately 9 million shares as those shares would be antidilutive due to the Companys net loss position. |
Second Quarter Earnings Announcement, Fiscal 2005
CABOT CORPORATION SUMMARY RESULTS BY SEGMENTS
Periods ended March 31 | Three Months | Six Months | ||||||||||||||
Dollars in millions, except per share amounts (unaudited) | 2005 | 2004 | 2005 | 2004 | ||||||||||||
SALES |
||||||||||||||||
Chemical Business |
$ | 427 | $ | 399 | $ | 832 | $ | 750 | ||||||||
Supermetals Business |
86 | 85 | 163 | 172 | ||||||||||||
Specialty Fluids |
8 | 9 | 15 | 10 | ||||||||||||
Segment
sales (A) |
521 | 493 | 1,010 | 932 | ||||||||||||
Unallocated
and other (B) |
6 | 7 | 12 | 14 | ||||||||||||
Net sales and other operating revenues |
$ | 527 | $ | 500 | $ | 1,022 | $ | 946 | ||||||||
SEGMENT PROFIT |
||||||||||||||||
Chemical Business |
$ | 46 | $ | 43 | $ | 82 | $ | 70 | ||||||||
Supermetals Business |
16 | 16 | 32 | 37 | ||||||||||||
Specialty Fluids |
4 | 3 | 6 | 1 | ||||||||||||
Total
Segment Profit
(C) |
66 | 62 | 120 | 108 | ||||||||||||
Interest expense |
(8 | ) | (7 | ) | (16 | ) | (15 | ) | ||||||||
General
unallocated income (expense) (D) |
(91 | ) | (3 | ) | (91 | ) | (2 | ) | ||||||||
Less: Equity in net income of affiliated companies, net of tax |
(2 | ) | (1 | ) | (4 | ) | (3 | ) | ||||||||
Income (loss) from continuing operations before income taxes |
(35 | ) | 51 | 9 | 88 | |||||||||||
Provision for income taxes |
(13 | ) | (13 | ) | (22 | ) | (21 | ) | ||||||||
Equity in net income of affiliated companies, net of tax |
2 | 1 | 4 | 3 | ||||||||||||
Minority interest in net income, net of tax |
(4 | ) | (3 | ) | (6 | ) | (4 | ) | ||||||||
Income (loss) from continuing operations |
(50 | ) | 36 | (15 | ) | 66 | ||||||||||
Discontinued operations |
||||||||||||||||
Income from operations of discontinued businesses, net of tax (E) |
| 1 | | | ||||||||||||
Net income (loss) |
(50 | ) | 37 | (15 | ) | 66 | ||||||||||
Dividends on preferred stock |
| (1 | ) | (1 | ) | (2 | ) | |||||||||
Income (loss) available to common shares |
$ | (50 | ) | $ | 36 | $ | (16 | ) | $ | 64 | ||||||
Diluted earnings per share of common stock |
||||||||||||||||
Income (loss) from continuing operations |
$ | (0.84 | ) | $ | 0.53 | $ | (0.26 | ) | $ | 0.96 | ||||||
Income from operations of discontinued businesses (E) |
$ | | $ | 0.01 | $ | | $ | | ||||||||
Net income (loss) |
$ | (0.84 | ) | $ | 0.54 | $ | (0.26 | ) | $ | 0.96 | ||||||
Weighted average common shares outstanding |
||||||||||||||||
Diluted
(F) |
60 | 69 | 60 | 69 |
(A) | Segment sales for certain operating segments within the Chemical Business include 100% of sales of one equity affiliate and transfers of materials at cost and at market-based prices. | |
(B) | Unallocated and other reflects an elimination for sales of one equity affiliate offset by royalties paid by equity affiliates and external shipping and handling costs. | |
(C) | Segment profit is a measure used by Cabots operating decision-makers to measure consolidated operating results and assess segment performance. Segment profit includes equity in net income of affiliated companies, royalties paid by equity affiliates, minority interest and allocated corporate costs. | |
(D) | General unallocated income (expense) includes foreign currency transaction gains (losses), interest income, dividend income, and the certain items listed in Exhibit I, including $90 million of goodwill impairment charges in the Supermetals Business. | |
(E) | Income represents settlement of litigation related to a previously divested business, net of tax. | |
(F) | The weighted average common shares outstanding at March 31, 2005 excludes approximately 9 million shares as those shares would be antidilutive due to the Companys net loss position. |
Second Quarter Earnings Announcement, Fiscal 2005
CABOT CORPORATION CONDENSED CONSOLIDATED FINANCIAL POSITION
March 31, | September 30, | |||||||
2005 | 2004 | |||||||
In millions | (unaudited) | |||||||
Current assets |
$ | 1,269 | $ | 1,173 | ||||
Net property, plant and equipment |
938 | 918 | ||||||
Other non-current assets |
229 | 335 | ||||||
Total assets |
$ | 2,436 | $ | 2,426 | ||||
Current liabilities |
$ | 490 | $ | 372 | ||||
Non-current liabilities |
765 | 863 | ||||||
Stockholders equity |
1,181 | 1,191 | ||||||
Total liabilities and stockholders
equity |
$ | 2,436 | $ | 2,426 | ||||
Working capital |
$ | 779 | $ | 801 | ||||
CABOT CORPORATION
Fiscal 2004 | Fiscal 2005 | |||||||||||||||||||||||||||||||||||||||
In millions, | ||||||||||||||||||||||||||||||||||||||||
except per share amounts (unaudited) | Dec. Q. | Mar. Q. | June Q. | Sept. Q. | FY | Dec. Q. | Mar. Q. | June Q. | Sept. Q. | FY | ||||||||||||||||||||||||||||||
Sales |
||||||||||||||||||||||||||||||||||||||||
Chemical Business |
$ | 351 | $ | 399 | $ | 398 | $ | 398 | $ | 1,546 | $ | 405 | $ | 427 | $ | 832 | ||||||||||||||||||||||||
Supermetals Business |
87 | 85 | 86 | 80 | 338 | 77 | 86 | 163 | ||||||||||||||||||||||||||||||||
Specialty Fluids |
1 | 9 | 4 | 13 | 27 | 7 | 8 | 15 | ||||||||||||||||||||||||||||||||
Segment Sales (A) |
439 | 493 | 488 | 491 | 1,911 | 489 | 521 | 1,010 | ||||||||||||||||||||||||||||||||
Unallocated and other (B) |
7 | 7 | 4 | 5 | 23 | 6 | 6 | 12 | ||||||||||||||||||||||||||||||||
Net sales and other operating revenues |
$ | 446 | $ | 500 | $ | 492 | $ | 496 | $ | 1,934 | $ | 495 | $ | 527 | $ | 1,022 | ||||||||||||||||||||||||
Segment Profit (Loss) |
||||||||||||||||||||||||||||||||||||||||
Chemical Business |
$ | 27 | $ | 43 | $ | 45 | $ | 17 | $ | 133 | $ | 36 | $ | 46 | $ | 82 | ||||||||||||||||||||||||
Supermetals Business |
21 | 16 | 18 | 22 | 76 | 16 | 16 | 32 | ||||||||||||||||||||||||||||||||
Specialty Fluids |
(2 | ) | 3 | | 5 | 6 | 2 | 4 | 6 | |||||||||||||||||||||||||||||||
Total
segment profit (loss) (C) |
46 | 62 | 63 | 44 | 215 | 54 | 66 | 120 | ||||||||||||||||||||||||||||||||
Income (Loss) Available to Common Shares |
||||||||||||||||||||||||||||||||||||||||
Interest expense |
(7 | ) | (7 | ) | (8 | ) | (8 | ) | (31 | ) | (8 | ) | (8 | ) | (16 | ) | ||||||||||||||||||||||||
General unallocated income (expense) (D) |
| (3 | ) | 2 | (14 | ) | (14 | ) | 1 | (91 | ) | (91 | ) | |||||||||||||||||||||||||||
Less: Equity in net income of affiliated companies, net of tax |
(2 | ) | (1 | ) | (2 | ) | (2 | ) | (6 | ) | (2 | ) | (2 | ) | (4 | ) | ||||||||||||||||||||||||
Income (Loss) from Continuing Operations before income taxes |
37 | 51 | 55 | 20 | 164 | 45 | (35 | ) | 9 | |||||||||||||||||||||||||||||||
(Provision) benefit for income taxes |
(8 | ) | (13 | ) | (13 | ) | (5 | ) | (40 | ) | (9 | ) | (13 | ) | (22 | ) | ||||||||||||||||||||||||
Equity in net income of affiliated companies, net of tax |
2 | 1 | 2 | 1 | 6 | 2 | 2 | 4 | ||||||||||||||||||||||||||||||||
Minority interest in net income, net of tax |
(1 | ) | (3 | ) | (3 | ) | (2 | ) | (9 | ) | (3 | ) | (4 | ) | (6 | ) | ||||||||||||||||||||||||
Income (Loss) from Continuing Operations |
30 | 36 | 41 | 14 | 121 | 35 | (50 | ) | (15 | ) | ||||||||||||||||||||||||||||||
Discontinued Operations |
||||||||||||||||||||||||||||||||||||||||
Income (Loss) from Operations of Discontinued Businesses,
net of income taxes (E) (F) |
(1 | ) | 1 | 1 | 1 | 2 | | | | |||||||||||||||||||||||||||||||
Net income (loss) |
29 | 37 | 42 | 15 | 123 | 35 | (50 | ) | (15 | ) | ||||||||||||||||||||||||||||||
Dividends on preferred stock |
(1 | ) | (1 | ) | | (1 | ) | (3 | ) | (1 | ) | | (1 | ) | ||||||||||||||||||||||||||
Income (loss) available to common shares |
$ | 28 | $ | 36 | $ | 42 | $ | 14 | $ | 120 | $ | 34 | $ | (50 | ) | $ | (16 | ) | ||||||||||||||||||||||
Income (Loss) per common share | ||||||||||||||||||||||||||||||||||||||||
Income
(Loss) per common share |
||||||||||||||||||||||||||||||||||||||||
Income (loss) from Continuing Operations |
$ | 0.43 | $ | 0.53 | $ | 0.61 | $ | 0.21 | $ | 1.79 | $ | 0.51 | $ | (0.84 | ) | $ | (0.26 | ) | ||||||||||||||||||||||
Income (Loss) from Operations of Discontinued Businesses (E) (F) |
(0.01 | ) | 0.01 | 0.01 | 0.02 | 0.03 | | | | |||||||||||||||||||||||||||||||
Net income
(loss) |
$ | 0.42 | $ | 0.54 | $ | 0.62 | $ | 0.23 | $ | 1.82 | $ | 0.51 | $ | (0.84 | ) | $ | (0.26 | ) | ||||||||||||||||||||||
Weighted average common shares outstanding |
||||||||||||||||||||||||||||||||||||||||
Diluted (G) |
68 | 69 | 69 | 68 | 68 | 69 | 60 | 60 | ||||||||||||||||||||||||||||||||
(A) | Segment sales for certain operating segments within the Chemical Business include 100% of sales of one equity affiliate and transfers of materials at cost and at market-based prices. | |
(B) | Unallocated and other reflects an elimination for sales for one equity affiliate offset by royalties paid by equity affiliates and external shipping and handling costs. | |
(C) | Segment profit is a measure used by Cabots operating decision-makers to measure consolidated operating results and assess segment performance. Segment profit includes equity in net income of affiliated companies, royalties paid by equity affiliates, minority interest and allocated corporate costs. | |
(D) | General unallocated income (expense) includes foreign currency transaction gains (losses), interest income, dividend income and certain items listed in Exhibit I, including $90 million of goodwill impairment charges in the Supermetals Business. | |
(E) | Amounts in Q1 2004 relate to litigation associated with a previously divested business, net of tax. | |
(F) | Additional income in Q2 2004, Q3 2004 and Q4 2004 related to insurance recoveries for discontinued businesses, net of tax. | |
(G) | The weighted average common shares outstanding at March 31, 2005 excludes approximately 9 million shares as those shares would be antidilutive due to the Companys net loss position. |
Second Quarter Earnings Announcement, Fiscal 2005
CABOT CORPORATION CERTAIN ITEMS Exhibit I
Periods ended March 31 | Three Months | Six Months | ||||||||||||||||||||||||||||||
Dollars in millions, except per share amounts (unaudited) | 2005 | 2005 | 2004 | 2004 | 2005 | 2005 | 2004 | 2004 | ||||||||||||||||||||||||
$ | per share(A) | $ | per share(A) | $ | per share(A) | $ | per share(A) | |||||||||||||||||||||||||
Certain items before income taxes |
||||||||||||||||||||||||||||||||
Restructuring initiatives |
$ | (4 | ) | $ | (0.04 | ) | $ | (2 | ) | $ | (0.02 | ) | $ | (8 | ) | $ | (0.08 | ) | $ | (3 | ) | $ | (0.03 | ) | ||||||||
Goodwill asset impairment |
(90 | ) | (1.30 | ) | | | (90 | ) | (1.30 | ) | | | ||||||||||||||||||||
Other non-operating items |
| | (1 | ) | (0.01 | ) | | | (1 | ) | (0.01 | ) | ||||||||||||||||||||
Impact of
change in shares for net loss (B) |
| (0.12 | ) | | | | (0.05 | ) | | | ||||||||||||||||||||||
Total certain items |
(94 | ) | (1.46 | ) | (3 | ) | (0.03 | ) | (98 | ) | (1.43 | ) | (4 | ) | (0.04 | ) | ||||||||||||||||
Discontinued operations |
| | 1 | 0.01 | | | | | ||||||||||||||||||||||||
Total certain items and discontinued operations pre-tax |
(94 | ) | (1.46 | ) | (2 | ) | (0.02 | ) | (98 | ) | (1.43 | ) | (4 | ) | (0.04 | ) | ||||||||||||||||
Tax impact
of certain items and discontinued operations (C) |
1 | | 1 | | 5 | 0.04 | 1 | - | ||||||||||||||||||||||||
Total certain items and discontinued operations after tax |
$ | (93 | ) | $ | (1.46 | ) | $ | (1 | ) | $ | (0.02 | ) | $ | (93 | ) | $ | (1.39 | ) | $ | (3 | ) | $ | (0.04 | ) | ||||||||
Periods ended March 31 | Three Months | Six Months | ||||||||||||||
Dollars in millions, except per share amounts (unaudited) | 2005 | 2004 | 2005 | 2004 | ||||||||||||
Statement of Operations Line Item |
||||||||||||||||
Cost of sales |
$ | (3 | ) | $ | (1 | ) | $ | (7 | ) | $ | (2 | ) | ||||
Selling and administrative expenses |
(1 | ) | (1 | ) | (1 | ) | (1 | ) | ||||||||
Goodwill
asset impairment |
(90 | ) | | (90 | ) | | ||||||||||
Other (charges) income |
| (1 | ) | | (1 | ) | ||||||||||
Total certain items |
$ | (94 | ) | $ | (3 | ) | $ | (98 | ) | $ | (4 | ) | ||||
(A) | Per share amounts are calculated after tax. | |
(B) | Due to the Companys net loss for the quarter and year to date periods ending March 31, 2005, common shares totaling 9 million are required to be excluded from the calculation of diluted earnings per share, as including them would have an antidilutive effect. However, in order to consistently present the per share impact of the certain items on the Companys results from period to period, the certain items are calculated using the Companys fully diluted weighted average common shares outstanding of 69 million. The impact of this change in the weighted average common shares outstanding on both continuing operations and certain items is reflected in this line. | |
(C) | Year to date amount includes $3 million of tax benefit related to the closure of the Altona facility. |